Prescient Therapeutics (ASX:PTX) is a clinical-stage biotech company developing personalised medicine approaches to cancer, including targeted and cellular therapies. Prescient’s technologies emanate from prestigious world class centres including Yale, Penn, Oxford and Moffitt. Targeted therapy: ...See more
Headquarters:
Australia
Company Type:
MNC / Large Enterprise
Company size:
11-50 Employees
Year Founded:
2014 (11 years)
Address:
LEVEL 11, 385 BOURKE STREET; SUITE 2; MELBOURNE, VICTORIA 3205, AU
LOW
spending power
